The HEAL-IST IDE Trial is underway to evaluate the safety and effectiveness of a new approach called hybrid sinus node sparing ablation in patients with symptomatic IST. Dr. Carlo de Asmundis explains the procedure & trial here: <a href="https://t.co/M5duGQViK6" target="_blank">https://t.co/M5duGQViK6</a>
<a href="https://twitter.com/hashtag/ClinicalTrial?src=hashtag_click" target="_blank">#ClinicalTrial</a> <a href="https://twitter.com/hashtag/IST?src=hashtag_click" target="_blank">#IST</a>
